Nilotinib: A Case of Acute Pancreatitis in a Patient With Chronic Myeloid Leukemia

被引:0
|
作者
Patel, Vihang [1 ]
Attia, Karim [1 ]
Pattisapu, Anil [1 ]
Weiss, John [1 ]
机构
[1] Mt Carmel Hlth Syst, Columbus, OH USA
来源
关键词
D O I
10.14309/00000434-201510001-00134
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
134
引用
收藏
页码:S56 / S56
页数:1
相关论文
共 50 条
  • [31] OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia
    Kiriyama, Hiroyuki
    Ishida, Junichi
    Kadowaki, Hiroshi
    Iwasa, Takeshi
    Kiyosue, Arihiro
    Kodera, Satoshi
    Ando, Jiro
    Akazawa, Hiroshi
    Komuro, Issei
    JACC: CARDIOONCOLOGY, 2019, 1 (02): : 318 - 321
  • [32] Nilotinib-Induced Dystonia and Cognitive Deficits in a Neurologically Normal Patient with Chronic Myeloid Leukemia
    Chan, Justine
    Shah, Paarth
    Moguel-Cobos, Guillermo
    CASE REPORTS IN NEUROLOGICAL MEDICINE, 2019, 2019
  • [33] Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Hijiya, Nobuko
    Zwaan, C. Michel
    Rizzari, Carmelo
    Foa, Robin
    Abbink, Floor
    Lancaster, Donna
    Landman-Parker, Judith
    Millot, Frederic
    Moppett, John
    Nelken, Brigitte
    Putti, Maria Caterina
    Tian, Xianbin
    Sinclair, Karen
    Santanastasio, Helene
    Buchbinder, Aby
    Kearns, Pamela
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 812 - 820
  • [34] A Case of Abdominal Sarcoidosis in a Patient with Acute Myeloid Leukemia
    Baskaran, Vadsala
    Goodwin, Amanda
    Athithan, Lavanya
    Rinaldi, Ciro Roberto
    Addeo, Alfredo
    CASE REPORTS IN HEMATOLOGY, 2013, 2013
  • [35] Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia
    Ciarcia, Roberto
    Damiano, Sara
    Puzio, Maria Valeria
    Montagnaro, Serena
    Pagnini, Francesco
    Pacilio, Carmen
    Caparrotti, Giuseppe
    Bellan, Cristiana
    Garofano, Tiziana
    Polito, Maria Sole
    Giordano, Antonio
    Florio, Salvatore
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (03) : 680 - 687
  • [36] Nilotinib: evaluation and analysis of its role in chronic myeloid leukemia
    Garland, Paula
    Apperley, Jane
    FUTURE ONCOLOGY, 2011, 7 (02) : 201 - 218
  • [37] Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients
    Boons, Christel C. L. M.
    Tromp, Vashti N. M. F.
    Neppelenbroek, Nienke J. M.
    Timmers, Lonneke
    van Schoor, Natasja M.
    Swart, Eleonora L.
    Hendrikse, N. Harry
    Janssen, Jeroen J. W. M.
    Hugtenburg, Jacqueline G.
    ACTA ONCOLOGICA, 2019, 58 (06) : 891 - 896
  • [38] Nilotinib Induced Keratosis Pilaris in a Female with Chronic Myeloid Leukemia
    Beniwal, Ranjana
    Agrawal, Akriti
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (02):
  • [39] Nilotinib as first-line therapy for chronic myeloid leukemia
    Vaid, A.
    INDIAN JOURNAL OF CANCER, 2011, 48 (04) : 438 - 445
  • [40] Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
    Saglio, Giuseppe
    Kim, Dong-Wook
    Issaragrisil, Surapol
    le Coutre, Philipp
    Etienne, Gabriel
    Lobo, Clarisse
    Pasquini, Ricardo
    Clark, Richard E.
    Hochhaus, Andreas
    Hughes, Timothy P.
    Gallagher, Neil
    Hoenekopp, Albert
    Dong, Mei
    Haque, Ariful
    Larson, Richard A.
    Kantarjian, Hagop M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24): : 2251 - 2259